Danaher Companies IDT and Aldevron Launch New mRNA Solutions for Gene Editing
Danaher subsidiaries Integrated DNA Technologies (IDT) and Aldevron have jointly launched research-grade mRNA solutions to streamline base and prime editing workflows.
Stocks · News reference
Danaher Corporation announced that President and CEO Julie Sawyer Montgomery will present at the UBS Global Healthcare Conference and the Jefferies Global Healthcare Conference in November 2026.
Reference Details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
Danaher subsidiaries Integrated DNA Technologies (IDT) and Aldevron have jointly launched research-grade mRNA solutions to streamline base and prime editing workflows.
Danaher subsidiary Cepheid has received U.S. FDA clearance for a new multiplex PCR test capable of detecting multiple viral hemorrhagic fever viruses from a single sample.
Beckman Coulter Diagnostics, a Danaher company, has received U.S. FDA clearance for its Access MeMed BV® assay, a blood test designed to help clinicians distinguish between bacterial and viral infections.
SCIEX, a Danaher company, has launched LeadScape, a new high-throughput workflow solution designed to accelerate drug candidate evaluation by automating compound optimization and analysis.
Danaher Corporation executives Matthew McGrew and Christopher Bouda disclosed the sale of company shares totaling over $8.7 million in SEC filings.
IDBS, a Danaher company, has expanded its partnership with a-tune software AG to integrate the tick@lab animal management platform with IDBS Polar.